NCT04516096 — Amyotrophic Lateral Sclerosis trial site landscape

Public-registry site landscape for NCT04516096, a Amyotrophic Lateral Sclerosis study sponsored by Amylyx Pharmaceuticals Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT04516096 (registry record)
Sponsor	Amylyx Pharmaceuticals Inc.
Condition(s)	Amyotrophic Lateral Sclerosis
Phase	PHASE2 / PHASE3
Listed sites	5
Site countries	United States

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT04516096 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →